Journal of Diagnostics Concepts & Practice ›› 2019, Vol. 18 ›› Issue (05): 570-574.doi: 10.16150/j.1671-2870.2019.05.016
• Original articles • Previous Articles Next Articles
ZHOU Lei1, WANG Hong1(), XU Huiming2, YE Tao3, GAO Jianping1, SUN Yijun1, XIE Jun1
Received:
2019-08-20
Online:
2019-10-25
Published:
2019-10-25
Contact:
WANG Hong
E-mail:13501762950@163.com
CLC Number:
ZHOU Lei, WANG Hong, XU Huiming, YE Tao, GAO Jianping, SUN Yijun, XIE Jun. The potential value of serum pepsinogen in screening of chronic atrophic gastritis among population with high risk for gastric cancer of Shanghai central urban area[J]. Journal of Diagnostics Concepts & Practice, 2019, 18(05): 570-574.
项目 | 无萎缩组 | 胃窦为主萎缩组 | 胃体为主萎缩组 | 胃广泛萎缩组 | P值 |
---|---|---|---|---|---|
人数[n(%)] | 61(34.26%) | 67(37.64%) | 29(16.29%) | 21(11.79%) | |
性别(男/女) | 25/36 | 32/34 | 15/14 | 13/8 | 0.392 |
年龄(岁) | 63.36±6.94 | 65.14±7.48 | 67.14±6.97 | 67.05±7.37 | 0.071 |
PGⅠ(μg/L) | 116.94±64.42 | 129.89±92.42 | 108.13±99.48 | 92.50±71.55 | >0.050 |
PGⅡ(μg/L) | 12.80±9.97 | 14.19±11.19 | 16.03±11.93 | 17.82±11.43 | >0.050 |
PGR | 11.97±6.85 | 12.37±9.72 | 6.93±4.95a) | 6.04±4.53b) | <0.001 |
[1] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424.
doi: 10.3322/caac.21492 URL |
[2] | 国家消化系统疾病临床医学研究中心, 中华医学会消化内镜学分会, 中华医学会健康管理学分会, 等. 中国早期胃癌筛查流程专家共识意见(草案)(2017年,上海)[J]. 胃肠病学, 2018, 23(2):92-97. |
[3] |
Venerito M, Nardone G, Selgrad M, et al. Gastric cancer--epidemiologic and clinical aspects[J]. Helicobacter, 2014, 19(Suppl 1):32-37.
doi: 10.1111/hel.12164 URL |
[4] |
Islami F, Sheikhattari P, Ren JS, et al. Gastric atrophy and risk of oesophageal cancer and gastric cardia adenocarcinoma--a systematic review and meta-analysis[J]. Ann Oncol, 2011, 22(4):754-760.
doi: S0923-7534(19)38545-X pmid: 20860989 |
[5] |
Kikuchi R, Abe Y, Iijima K, et al. Low serum levels of pepsinogen and gastrin 17 are predictive of extensive gastric atrophy with high-risk of early gastric cancer[J]. Tohoku J Exp Med, 2011, 223(1):35-44.
doi: 10.1620/tjem.223.35 URL |
[6] |
Vannella L, Lahner E, Annibale B. Risk for gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisal[J]. World J Gastroenterol, 2012, 18(12):1279-1285.
doi: 10.3748/wjg.v18.i12.1279 URL |
[7] | Hosseini M, Amoueian S, Attaranzadeh A, et al. Serum gastrin 17, pepsinogen I and pepsinogen II in atrophic gastritis patients living in North-East of Iran[J]. J Res Med Sci, 2013, 18(3):225-229. |
[8] |
Lomba-Viana R, Dinis-Ribeiro M, Fonseca F, et al. Serum pepsinogen test for early detection of gastric cancer in a European country[J]. Eur J Gastroenterol Hepatol, 2012, 24(1):37-41.
doi: 10.1097/MEG.0b013e32834d0a0a URL |
[9] |
Nasrollahzadeh D, Aghcheli K, Sotoudeh M, et al. Accuracy and cut-off values of pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy: influence of gastritis[J]. PLoS One, 2011, 6(10):e26957.
doi: 10.1371/journal.pone.0026957 URL |
[10] |
Graham DY, Nurgalieva ZZ, El-Zimaity HM, et al. Noninvasive versus histologic detection of gastric atrophy in a Hispanic population in North America[J]. Clin Gastroenterol Hepatol, 2006, 4(3):306-314.
doi: 10.1016/j.cgh.2005.11.003 URL |
[11] |
Samloff IM. Pepsinogens I and II: purification from gastric mucosa and radioimmunoassay in serum[J]. Gastroenterology, 1982, 82(1):26-33.
pmid: 7053333 |
[12] |
Gritti I, Banfi G, Roi GS. Pepsinogens: physiology, pharmacology pathophysiology and exercise[J]. Pharmacol Res, 2000, 41(3):265-281.
pmid: 10675278 |
[13] |
Sipponen P. Update on the pathologic approach to the diagnosis of gastritis, gastric atrophy, and Helicobacter pylori and its sequelae[J]. J Clin Gastroenterol, 2001, 32(3):196-202.
pmid: 11246343 |
[14] |
Hansen S, Vollset SE, Derakhshan MH, et al. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status[J]. Gut, 2007, 56(7):918-925.
pmid: 17317788 |
[15] |
Bornschein J, Selgrad M, Wex T, et al. Serological assessment of gastric mucosal atrophy in gastric cancer[J]. BMC Gastroenterol, 2012, 12:10.
doi: 10.1186/1471-230X-12-10 pmid: 22289789 |
[16] |
Leja M, Kupcinskas L, Funka K, et al. The validity of a biomarker method for indirect detection of gastric muco-sal atrophy versus standard histopathology[J]. Dig Dis Sci, 2009, 54(11):2377-2384.
doi: 10.1007/s10620-009-0947-5 URL |
[17] |
Kikuchi S, Kato M, Katsuyama T, et al. Design and planned analyses of an ongoing randomized trial asses-sing the preventive effect of Helicobacter pylori eradication on occurrence of new gastric carcinomas after endoscopic resection[J]. Helicobacter, 2006, 11(3):147-151.
pmid: 16684261 |
[18] |
He CY, Sun LP, Gong YH, et al. Serum pepsinogen II: a neglected but useful biomarker to differentiate between diseased and normal stomachs[J]. J Gastroenterol Hepatol, 2011, 26(6):1039-1046.
doi: 10.1111/j.1440-1746.2011.06692.x URL |
[19] | Chae H, Lee JH, Lim J, et al. Clinical utility of serum pepsinogen levels as a screening test of atrophic gastritis[J]. Korean J Lab Med, 2008, 28(3):201-206. |
[20] |
Zoalfaghari A, Aletaha N, Roushan N, et al. Accuracy of pepsinogens for early diagnosis of atrophic gastritis and gastric cancer in Iranian population[J]. Med J Islam Repub Iran, 2014, 28:150.
pmid: 25695008 |
[21] | Chae H, Lee JH, Lim J, et al. Clinical utility of serum pepsinogen levels as a screening test of atrophic gastritis[J]. Korean J Lab Med, 2008, 28(3):201-206. |
[22] |
Zoalfaghari A, Aletaha N, Roushan N, et al. Accuracy of pepsinogens for early diagnosis of atrophic gastritis and gastric cancer in Iranian population[J]. Med J Islam Repub Iran, 2014, 28:150.
pmid: 25695008 |
[23] |
Pimentel-Nunes P, Libanio D, Marcos-Pinto R, et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019[J]. Endoscopy, 2019, 51(4):365-388.
doi: 10.1055/a-0859-1883 pmid: 30841008 |
[24] |
Lomba-Viana R, Dinis-Ribeiro M, Fonseca F, et al. Serum pepsinogen test for early detection of gastric cancer in a European country[J]. Eur J Gastroenterol Hepatol, 2012, 24(1):37-41.
doi: 10.1097/MEG.0b013e32834d0a0a URL |
[1] | YANG Ruixin, DU Yutong, YAN Ranlin, ZHU Zhenggang, LI Chen, YU Yingyan. Improving exploration of biological sample pretreatment in single-cell transcriptome sequencing of gastrointestinal tumors [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(05): 567-574. |
[2] | LI Nana, QI Tao, ZHU Liming. Clinical value of serum pepsinogen,gastrin 17 and Helicobacter pylori IgG antibody in primary screening of gastric diseases [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(04): 509-513. |
[3] | YANG Cuiping, YANG Xiaojin, YANG Yanpin, ZHANG Mengyin, XIE Ling, YU Xiaojun, CAI Boer, CHEN Dengyu, CHEN Ping, WU Yunlin. Functional study and detection of vimentin produced by miR-200c target gene in human gastric cancer BGC823 cells [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(04): 414-419. |
[4] | JIANG Jiang, ZENG Zhikun, SHI Bowen, PAN Zhaocheng, YAN Ling, WANG Yujie, ZHANG Huan. Study on motion characteristics of gastric cancer cells using glassy dynamics analysis [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(06): 645-648. |
[5] | WANG Lan, ZHANG Huan, GE Yingqian, LU Jing, CUI Zheng, YAN Ling, PAN Zilai. Clinical application and evaluation of artificial intelligence-assisted semi-automatic segmentation software for detection of liver metastases from gastric cancer: intra-observer and inter-observer differences [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(05): 515-520. |
[6] | ZHANG Hua, LI Yongxing, LE Yan, WANG Wenyu, XIANG Mingjie. Use of combined detection of serum OPN and TPS in diagnosis of gastric cancer [J]. Journal of Diagnostics Concepts & Practice, 2018, 17(04): 428-432. |
[7] | WU Xinyang, ZHANG Huan, PAN Zilai, TAN Jingwen, GAO Xiaoyuan. The diagnostic value of dual-source CT in differentiating primary gastric lymphoma from advanced gastric cancer [J]. Journal of Diagnostics Concepts & Practice, 2018, 17(01): 60-65. |
[8] | QIAO Changting, LI Lei, WU Anni, YUAN Fei. Relationship between HER2 expression and clinicopathological features in advanced gastric cancer [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(02): 166-170. |
[9] | . [J]. Journal of Diagnostics Concepts & Practice, 2016, 15(02): 174-179. |
[10] | . [J]. Journal of Diagnostics Concepts & Practice, 2015, 14(06): 522-527. |
[11] | . [J]. Journal of Diagnostics Concepts & Practice, 2014, 13(06): 597-601. |
[12] | . [J]. Journal of Diagnostics Concepts & Practice, 2014, 13(04): 383-387. |
[13] | . [J]. Journal of Diagnostics Concepts & Practice, 2013, 12(03): 284-289. |
[14] | . [J]. Journal of Diagnostics Concepts & Practice, 2013, 12(01): 57-61. |
[15] | . [J]. Journal of Diagnostics Concepts & Practice, 2013, 12(01): 65-69. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||